No Data
Omeros Corporation to Announce First Quarter Financial Results on May 15, 2024
Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its financial results for the quarter and year ended March 31, 2024, on Wednesday, May 15, 2024, after the market closes. Omeros management will host a conference call and webcast that same day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss the financial results as well as recent developments and highlights.
Omeros Corporation Announces Upcoming Presentations at 2024 European Hematology Association (EHA) Hybrid Congress
Omeros Corporation (Nasdaq: OMER) today announced that interim analysis data from its ongoing Phase 2 study of OMS906 in patients with paroxysmal nocturnal hemoglobinuria submitted to the 2024 European Hematology Association (EHA) Hybrid Congress has been selected for podium presentation.
Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (ORIC), Omeros (OMER) and Urogen Pharma (URGN)
Omeros Corporation's $50M Buyback Plan: A Double-Edged Sword for Stock Stability
Omeros Shares Down 6% on Swing to 4Q Loss
By Denny Jacob Omeros shares edged down 6% to $3 a reporting a swing to a loss in the fourth quarter. The stock is down 8.3% so far this year. The biopharmaceutical company posted a loss of $9.1 mi
Express News | CORRECTION: Omeros Q4 EPS $(0.63) Misses $(0.55) Estimate